BONDURANT STUART 4/A
4/A · Furiex Pharmaceuticals, Inc. · Filed Dec 7, 2011
Insider Transaction Report
Form 4/AAmended
BONDURANT STUART
Director
Transactions
- Award
Stock Options (to buy)
2011-10-12+8,825→ 8,825 totalExercise: $13.45Exp: 2021-10-12→ Common Stock (8,825 underlying)
Footnotes (2)
- [F1]This amended Form 4 is being filed to correct the footnote description. The original Form 4 filed on October 14, 2011, incorrectly stated the options would vest in full on the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors. The corrected footnote appears in footnote #2.
- [F2]The options were awarded on October 12, 2011 and vest and become exercisable in full on the earlier of May 19, 2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.